Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
ESC Working Group on Cardiovascular Pharmacotherapy shared a post on LinkedIn about a recent article by Marcello Di Nisio and Tzu-Fei Wang, published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:
“New in EHJ-CVP | Viewpoint
Beyond API-CAT: who should continue anticoagulation, and for how long?
API-CAT showed that reduced-dose apixaban preserves efficacy while reducing bleeding during extended anticoagulation for cancer-associated thrombosis.
Yet, while it answers how intensely we should anticoagulant, two key questions remain: who should continue treatment and for how long?
In this Viewpoint, Marcello Di Nisio and Tzu-Fei Wang argue that extended anticoagulation should be a dynamic process of benefit–risk reassessment, adapting to cancer status, bleeding risk, prognosis and patients’ preferences.
The future may lie not only in safer doses, but in the right treatment, for the right patient, for the right duration.”
Title: Beyond API-CAT: the remaining challenges of extended anticoagulation for cancer-associated thrombosis
Authors: Marcello Di Nisio, Tzu-Fei Wang

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?